2003
DOI: 10.1074/jbc.m304693200
|View full text |Cite
|
Sign up to set email alerts
|

Crystal Structure of the Yersinia Protein-tyrosine Phosphatase YopH Complexed with a Specific Small Molecule Inhibitor

Abstract: The pathogenic bacteria Yersinia are causative agents in human diseases ranging from gastrointestinal syndromes to bubonic plague. There is increasing risk of misuse of infectious agents, such as Yersinia pestis, as weapons of terror as well as instruments of warfare for mass destruction. Because the phosphatase activity of the Yersinia protein tyrosine phosphatase, YopH, is essential for virulence in the Yersinia pathogen, potent and selective YopH inhibitors are expected to serve as novel anti-plague agents.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
80
0
2

Year Published

2004
2004
2022
2022

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 59 publications
(85 citation statements)
references
References 48 publications
3
80
0
2
Order By: Relevance
“…The ability of BBP-based probes to target the PTP active site was expected because BBP mimics pTyr, which is known to occupy the PTP active site. Indeed, the K I values for probe I and BBP are similar to competitive inhibition constants measured for benzylphosphonate, a nonhydrolyzable pTyr mimetic (11). Further evidence in support of the inactivation's being directed to the active site included the fact that arsenate, a competitive PTP inhibitor, was able to protect PTP from BBP-mediated inactivation.…”
Section: Design and Synthesis Of Biotinylated Bbps As Activity-based Ptpmentioning
confidence: 56%
See 2 more Smart Citations
“…The ability of BBP-based probes to target the PTP active site was expected because BBP mimics pTyr, which is known to occupy the PTP active site. Indeed, the K I values for probe I and BBP are similar to competitive inhibition constants measured for benzylphosphonate, a nonhydrolyzable pTyr mimetic (11). Further evidence in support of the inactivation's being directed to the active site included the fact that arsenate, a competitive PTP inhibitor, was able to protect PTP from BBP-mediated inactivation.…”
Section: Design and Synthesis Of Biotinylated Bbps As Activity-based Ptpmentioning
confidence: 56%
“…The inactivation reaction was initiated by the addition of a 5-l aliquot of PTP stock to a 45-l solution containing appropriately diluted probe I (final concentration of DMSO, 5%). At appropriate time intervals, aliquots of 2 l were removed from the reaction and added to a 200-l solution containing 20 mM pnitrophenyl phosphate (pNPP) in pH 6.0 buffer at 30°C (11). The kinetic parameters of the inactivation reaction were obtained by fitting the data to the following equations: Western Blot Analyses of the Labeling Reaction.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…17 Other recombinant PTPs were expressed and purified as described previously. [18][19][20] Non-PTP enzymes were purchased from Sigma-Aldrich and stored at −20 °C.…”
Section: Ptps and Non-ptp Proteinsmentioning
confidence: 99%
“…Furthermore, the co-crystal structure of a Yersinia tyrosine phosphatase (YopH) complexed with a small molecule inhibitor has been solved (52). This inhibitor is p-nitrocatachol sulfate, the same compound that was co-crystallized in the substrate binding site of arylsulfatase (Fig.…”
mentioning
confidence: 99%